HCA Healthcare 3Q 2026: Revenue $19.849B, Net income $1.579B, EPS $7.27— 10-Q Summary

HCA Healthcare reported 3Q 2026 revenue of $19.849B, up 3.6% YoY, with net income declining 3.9% to $1.579B. EPS rose 4.5% to $7.27. Admissions increased, but surgeries declined. Uninsured admissions surged 27.4%, pressuring managed-care revenue. Costs varied, with efficiency initiatives underway. Capital spending is projected at $5.0B-$5.5B, excluding acquisitions.

Original reporting
Published Oct 29, 2026, 8:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HCA Healthcare 3Q 2026: Revenue $19.849B, Net income $1.579B, EPS $7.27— 10-Q Summary — source image
Decision brief

The 30-second read

$HCABullishMed
01

Why it matters

Traders can use the reported quarter metrics and operating drivers (admissions mix, surgery volumes, cost structure, uninsured admissions) to reassess near-term earnings power and margin risk.

02

Market read

A fresh quarterly disclosure with specific income statement figures and operating drivers that can shift expectations for margins and reimbursement dynamics.

03

What to watch

The summary flags inflation-driven expense pressure and managed-care revenue pressure, but does not quantify guidance or segment margins, which may be the key swing factor for traders.

Relevance 7/10Novelty 6/10Timing: 10-Q summary published for 3Q 2026 results, available for same-day positioning

Background

The piece is an AI summary of HCA’s 3Q 2026 10-Q filed Oct. 29, 2026, highlighting revenue, net income, EPS, and selected operating metrics.

Company-level read

Ticker impact

$HCABullishMedium confidence
Context

HCA reported 3Q 2026 revenue of $19.849B (+3.6% YoY) and diluted EPS of $7.27 (+4.5% YoY) in its 10-Q summary.

Expected impact

Likely mixed market reaction as EPS rises but net income falls, with investors focusing on managed-care pressure and cost inflation.

Evidence & confidence

The article provides the quarter’s core income statement metrics and specific operating drivers (uninsured admissions up, inpatient/outpatient surgery declines, expense mix shift), which can offset each other for near-term sentiment.

Market effects

Hospital operators may face similar managed-care and cost inflation dynamics; admissions mix shifts (uninsured up) can pressure revenue quality.

No explicit regional breakdown provided; impact is primarily company-specific within US healthcare services.

Limited global relevance; US healthcare demand and reimbursement mix are the main themes.

Counterpoint

EPS growth could be driven by fewer diluted shares rather than underlying operating leverage, so the quality of earnings may be weaker than headline EPS suggests.

Key entities

  • HCA Healthcare, Inc.

    US hospital operator reporting 3Q 2026 revenue, net income, EPS, and operating highlights in a 10-Q summary.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$CNCMed

Health insurers, hospitals rally after sweeping midterm win for Democrats

Shares of Medicaid-focused health insurers (Centene, Elevance, Molina) and hospital operators (HCA, Tenet, Universal) rose after Democrats won the midterms, raising hopes for sector-friendly policies. Analysts expect delays in Trump's OBBBA, easing pressure on Medicaid and ACA insurers, and potential extensions of enhanced subsidies. Year-to-date gains vary among companies.

$TSLAHighAI 8/10

Tesla, SpaceX And AI Stocks Slide After Democrats Take Congress

Stock futures rose premarket after Democrats took control of Congress. Renewable energy and healthcare stocks gained, while AI-linked and Texas-based companies like Tesla (TSLA) and SpaceX fell. Oracle (ORCL) and Nvidia (NVDA) also declined on data center concerns. Trump Media & Technology Group (DJT) shares dropped 11%.